The trademark application ITEOS CANCER IMMUNOTHERAPIES BY DESIGN was filed by ITeos Belgium SA, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on May 26, 2021, and it was registered by office on September 2, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.